These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 29687840

  • 1. Effects of miR-214 on cervical cancer cell proliferation, apoptosis and invasion via modulating PI3K/AKT/mTOR signal pathway.
    Wang F, Tan WH, Liu W, Jin YX, Dong DD, Zhao XJ, Liu Q.
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1891-1898. PubMed ID: 29687840
    [Abstract] [Full Text] [Related]

  • 2. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
    Zhang S, Wang M, Li Q, Zhu P.
    Cancer Biomark; 2017 Dec 12; 21(1):179-186. PubMed ID: 29081412
    [Abstract] [Full Text] [Related]

  • 3. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y, Xie L, Xu S, Yan W, Zhang H, Meng Y, Liu J, Wei X.
    Mol Cell Biochem; 2021 Nov 12; 476(11):4031-4044. PubMed ID: 34244973
    [Abstract] [Full Text] [Related]

  • 4. MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
    Fu JH, Yang S, Nan CJ, Zhou CC, Lu DQ, Li S, Mu HQ.
    Eur Rev Med Pharmacol Sci; 2018 Jan 12; 22(2):351-357. PubMed ID: 29424922
    [Abstract] [Full Text] [Related]

  • 5. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    Teng P, Jiao Y, Hao M, Tang X.
    J Cell Biochem; 2018 Jul 12; 119(7):5243-5252. PubMed ID: 29236322
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ, Wang Y, Wang YY.
    J Cell Physiol; 2019 Jun 12; 234(6):9577-9591. PubMed ID: 30480801
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW, Wang SH, Wei X, Hou YZ, Li ZH.
    Eur Rev Med Pharmacol Sci; 2020 Dec 12; 24(24):12655-12666. PubMed ID: 33378012
    [Abstract] [Full Text] [Related]

  • 8. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L, Liu M, Zhang Z, Zhang W, Liu N, Sheng X, Wei P.
    Biol Res; 2019 Feb 27; 52(1):8. PubMed ID: 30808417
    [Abstract] [Full Text] [Related]

  • 9. miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer.
    Lu R, Yang Z, Xu G, Yu S.
    Biomed Pharmacother; 2018 Sep 27; 105():633-644. PubMed ID: 29898430
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K, Zhang T, Fan Y, Serick, Du G, Wu P, Geng D.
    Tumour Biol; 2016 Oct 27; 37(10):13469-13477. PubMed ID: 27465551
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
    Lv X, Li CY, Han P, Xu XY.
    Eur Rev Med Pharmacol Sci; 2018 Apr 27; 22(8):2321-2327. PubMed ID: 29762835
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.
    Wu YR, Qi HJ, Deng DF, Luo YY, Yang SL.
    Tumour Biol; 2016 Sep 27; 37(9):12061-12070. PubMed ID: 27188433
    [Abstract] [Full Text] [Related]

  • 13. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y, Li S, Li J, Wang D, Li Q.
    Cell Physiol Biochem; 2017 Sep 27; 42(4):1431-1446. PubMed ID: 28715819
    [Abstract] [Full Text] [Related]

  • 14. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X, Dong J, He X, Shen L, Long C, Liu F, Liu X, Lin T, He D, Wei G.
    Biomed Pharmacother; 2020 May 27; 125():109880. PubMed ID: 32004974
    [Abstract] [Full Text] [Related]

  • 15. SRSF3 Restriction Eases Cervical Cancer Cell Viability and Metastasis via Adjusting PI3K/AKT/mTOR Signaling Pathway.
    Zhang L, Li J, Zhang L.
    Contrast Media Mol Imaging; 2022 May 27; 2022():8497078. PubMed ID: 36237584
    [Abstract] [Full Text] [Related]

  • 16. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
    Yang W, Xie T.
    Reprod Sci; 2020 Jan 27; 27(1):132-144. PubMed ID: 32046405
    [Abstract] [Full Text] [Related]

  • 17. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H, Pu J, Zhou XL, Ning YY, Bai C.
    Tumour Biol; 2017 May 27; 39(5):1010428317697568. PubMed ID: 28459375
    [Abstract] [Full Text] [Related]

  • 18. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.
    Li G, Cai M, Fu D, Chen K, Sun M, Cai Z, Cheng B.
    Cell Physiol Biochem; 2012 May 27; 30(6):1481-90. PubMed ID: 23208072
    [Abstract] [Full Text] [Related]

  • 19. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
    Dai C, Xie Y, Zhuang X, Yuan Z.
    Biomed Pharmacother; 2018 Aug 27; 104():763-770. PubMed ID: 29807226
    [Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J, Feng L, Tian C, Tang YL, Tang Y, Hu FQ.
    Eur Rev Med Pharmacol Sci; 2018 Dec 27; 22(23):8135-8144. PubMed ID: 30556851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.